医学
物理疗法
随机对照试验
康复
物理医学与康复
等长运动
髌腱
阻力训练
蹲下
慢性疼痛
磁共振成像
运动范围
临床试验
骨关节炎
膝关节
力量训练
肌腱
评定量表
超声科
肌腱病
患者满意度
髌韧带
随机化
作者
Mikkel Holm Hjortshoej,Hemant Juneja,René B. Svensson,Robert Bennike Herzog,Mathilde Lundgaard‐Nielsen,Frederik Kronvold Nielsen,Mette With Wulff,Amanda Emilie Olsen,Janus Damm Nybing,Philip Hansen,Jesper Petersen,Michael Kjaer,Per Aagaard,S. Peter Magnusson,Christian Couppé
摘要
Patellar tendinopathy (PT) is a debilitating overuse injury, and one of the current recommended treatments is heavy slow resistance training (HSRT); Recently, low-load resistance training combined with blood flow restriction (LL-BFRT) has been advocated as a clinically relevant rehabilitation tool for PT since it does not involve large joint and tissue stresses and may accelerate recovery. This study aimed to investigate the effect of LL-BFRT compared with HSRT at 3, 6, 12 (primary endpoint), and 52 weeks. Participants with chronic unilateral PT were randomized to a 12-week rehabilitation program based on either LL-BFRT (n = 16) or HSRT (n = 20). The primary outcome was pain (numerical rating scale (NRS) 0-10) during a single-leg decline squat (SLDS). Secondary outcome variables included the Victorian Institute of Sports Assessment-Patella questionnaire (VISA-P), maximal isometric knee extensor strength, patellar tendon morphology assessed by ultrasonography (swelling, vascularization), and magnetic resonance imaging (MRI). Comparable clinically relevant improvements in pain (NRS during SLDS, least squares mean ± SEM) were observed in LL-BFRT (LL-BFRT: 0 weeks 3.9 ± 0.5, 12 weeks 2.2 ± 0.5, 52 weeks 1.8 ± 0.5) and HSRT (0 weeks 4.2 ± 0.4, 12 weeks 2.2 ± 0.4, 52 weeks 1.1 ± 0.5) (p < 0.0001). Likewise, clinically relevant improvements were reported on the VISA-P score. LL-BFRT and HSRT resulted in comparable short-term and long-term clinical improvements in males with chronic PT. These data advocate that LL-BFRT represents an effective rehabilitation tool in the treatment of chronic PT, while preventing high joint and tendon loads. Trial Registration: Clinicaltrials.org (NCT04550013).
科研通智能强力驱动
Strongly Powered by AbleSci AI